← Back to Search

Behavioural Intervention

At-home tDCS for Autism

Phase 2

Recruiting

Research Sponsored by Holland Bloorview Kids Rehabilitation Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Children with a diagnosis of autism spectrum disorder and self-regulation impairment or social communication challenges

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0 weeks, 6 weeks, 18 weeks

Awards & highlights

Study Summary

This trial explores if a safe, non-invasive brain stimulation can help improve social communication and self-regulation in youth with Autism Spectrum Disorder.

Who is the study for?

This trial is for children with Autism Spectrum Disorder (ASD) who have difficulties with self-regulation or social communication. They must be able to participate in at-home brain stimulation treatments.Check my eligibility

What is being tested?

The study tests if a home-based brain stimulation technique, called tDCS, can help improve social communication and behavior in kids with ASD. Participants are randomly assigned to either the real tDCS or a sham (fake) treatment for three weeks.See study design

What are the potential side effects?

tDCS is generally safe and tolerable. Possible side effects may include mild discomfort at the site of stimulation, itching, tingling during the application, headache, fatigue, and nausea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child has autism with difficulties in self-regulation or social communication.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0 weeks, 6 weeks, 18 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0 weeks, 6 weeks, 18 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 weeks, 6 weeks, 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence

Attrition

Blinding

+1 more

Secondary outcome measures

Inhibitory control

Magnetic Resonance Imaging (MRI)

Overall Clinical Change

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: tDCSExperimental Treatment1 Intervention

active tDCS

Group II: ShamPlacebo Group1 Intervention

sham tDCS

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Holland Bloorview Kids Rehabilitation HospitalLead Sponsor

67 Previous Clinical Trials

14,054 Total Patients Enrolled

23 Trials studying Autism Spectrum Disorder

8,841 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the qualifications for participating in this experiment?

"This study, which is accepting 20 participants in total, requires that applicants have a diagnosis of autism and are aged between 9 and 18."

Answered by AI

Is enrollment still open for this clinical experiment?

"According to the records hosted on clinicaltrials.gov, this medical research is still enrolling candidates. The trial was first advertised on October 20th of 2023 and its progress was updated as recently as November 8th of the same year."

Answered by AI

Do the potential advantages of tDCS outweigh its risks for users?

"There is limited clinical data confirming the safety of tdcs, resulting in a score of 2. Unfortunately, there is no evidence yet supporting its efficacy."

Answered by AI

Is the eligibility for this trial limited to seniors aged 50 and up?

"This particular trial is for individuals aged between 9 and 18 years old. According to the data, there are 267 medical studies recruiting participants of a similar age group, while 54 trials are open to patients over 65."

Answered by AI

What is the current enrollment capacity for this clinical experiment?

"Affirmative. Details published on clinicaltrials.gov confirm that this medical trial, which went live October 20th of 2021, is actively seeking participants. The research team needs to find approximately 20 patients from just one centre for the study to go forward."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Home-based Transcranial Direct Current Stimulation (tDCS) to Promote Social Communication and Behaviour in Children With Autism Spectrum Disorder (ASD)

2023. "Home-based Transcranial Direct Current Stimulation (tDCS) to Promote Social Communication and Behaviour in Children With Autism Spectrum Disorder (ASD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06129058.

All > Tdcs